Polycystic ovary syndrome in asian women.
There is substantial heterogeneity of symptoms and signs among women with polycystic ovary syndrome (PCOS). In addition to different diagnostic criteria used, the ethnic background of women with PCOS may affect the clinical, hormonal, and metabolic characteristics of this condition. We present here studies related to the clinical, hormonal, and metabolic characteristics and response to the treatment of PCOS in Asia, which may be different from those in Western countries. It is important to take into consideration the ethnic background of patients in future studies related to PCOS.
Yu Ng
Ernest Hung
EH
Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. nghye@hkucc.hku.hk
Ho
Pak Chung
PC
D001208:Asia / Q000453:epidemiology; D002996:Clomiphene / Q000627:therapeutic use; D005260:Female; D005300:Fertility Agents, Female / Q000627:therapeutic use; D006062:Gonadotropins / Q000627:therapeutic use; D029001:Herbal Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D010048:Ovarian Cysts / Q000209:etiology; D010053:Ovary / Q000098:blood supply / Q000378:metabolism / Q000601:surgery; D010062:Ovulation Induction / Q000009:adverse effects / Q000379:methods; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000208:ethnology* / Q000378:metabolism / Q000628:therapy
D005300:Fertility Agents, Female; D006062:Gonadotropins; D007004:Hypoglycemic Agents; D002996:Clomiphene